Explore
Trendline
Exelixis Reports Q1 2026 Financial Results and Announces New Drug Developments
Exelixis Reports Q1 2026 Financial Results and Announces New Drug Developments
Read More
Trendline
Zai Lab Reports Q1 2026 Financial Results and Advances Oncology Pipeline
Zai Lab Reports Q1 2026 Financial Results and Advances Oncology Pipeline
Read More
Trendline
Sarepta Therapeutics Reports Q1 2026 Financial Results Amidst Strategic Developments
Sarepta Therapeutics Reports Q1 2026 Financial Results Amidst Strategic Developments
Read More
Trendline
Janux Therapeutics Reports Q1 2026 Financial Results and Pipeline Progress
Janux Therapeutics Reports Q1 2026 Financial Results and Pipeline Progress
Read More
Trendline
TORL BioTherapeutics Appoints Aran Maree as CEO to Drive Growth in Cancer Therapeutics
TORL BioTherapeutics Appoints Aran Maree as CEO to Drive Growth in Cancer Therapeutics
Read More
Trendline
DiaMedica Therapeutics Reports Financial Results and Advances Clinical Trials for Preeclampsia and Stroke
DiaMedica Therapeutics Reports Financial Results and Advances Clinical Trials for Preeclampsia and Stroke
Read More
Trendline
Travere Therapeutics Reports Significant Growth in Q1 2026 Financial Results
Travere Therapeutics Reports Significant Growth in Q1 2026 Financial Results
Read More
Trendline
Summit Shares Plummet as Cancer Drug Fails Early Survival Benchmark
Summit Shares Plummet as Cancer Drug Fails Early Survival Benchmark
Read More
Trendline
Nuvectis Pharma Reports Increased Net Loss in Q1 2026 Amid Clinical Expansion
Nuvectis Pharma Reports Increased Net Loss in Q1 2026 Amid Clinical Expansion
Read More
Trendline
Nuvectis Pharma Reports Increased Net Loss in Q1 2026
Nuvectis Pharma Reports Increased Net Loss in Q1 2026
Read More
Trendline
IDEAYA Biosciences Reports Positive Trial Results and Financial Update for Q1 2026
IDEAYA Biosciences Reports Positive Trial Results and Financial Update for Q1 2026
Read More
Trendline
Agenus to Release Q1 2026 Financial Results and Corporate Update
Agenus to Release Q1 2026 Financial Results and Corporate Update
Read More
